Meeting
2018 ASCO Annual Meeting
Comparison between lobaplatin and cisplatin plus 5-fluorouracil combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: A multicenter randomized phase III clinical trial.
Authors
Kuiyuan Liu
Sun Yat-Sen University Cancer Center, Guangzhou, China
Kuiyuan Liu , Wei-Xiong Xia , Wen-Ze Qiu , Ya-Hui Yu , Guo-Ying Liu , Hu Liang , Wang-Zhong Li , Shu-Hui Lv , Liang-Ru Ke , Hao-Yuan Mo , Guo Ling , Ming-Yuan Chen , Ka-Jia Cao , Chong Zhao , Chao-Nan Qian , Xing Lv , Xiang Yanqun , Xiang Guo , Xin-Jun Huang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Advanced/Metastatic Disease
Clinical Trial Registration Number
ChiCTR-TRC-13003285
Citation
J Clin Oncol 36, 2018 (suppl; abstr 6029)
DOI
10.1200/JCO.2018.36.15_suppl.6029
Abstract #
6029
Poster Bd #
17
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Recombinant human endostatin combined with intensity-modulated radiotherapy in low-risk locoregionally advanced nasopharyngeal carcinoma: A phase II, randomized, multicenter clinical trial.
First Author: Min Kang
Poster
2017 ASCO Annual Meeting
Phase III randomized trial of image-guided bone marrow-sparing intensity modulated radiation therapy (IG-BMS-IMRT) for locoregionally advanced cervical cancer: The INTERTECC-3 trial.
First Author: Loren K. Mell
Poster
2014 ASCO Annual Meeting
Pharmacokinetic and pharmacogenetic analysis in patients with advanced nasopharyngeal carcinoma (NPC) treated with 5-flurouracil (5-FU) and cisplatin.
First Author: Yuxiang Ma